Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|September 3, 2024
Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapseAdam Phillip Gordon Braun, Alex Herrera
Current Hematologic Malignancy Reports|January 7, 2021
Emerging Therapies in Relapsed and Refractory Hodgkin Lymphoma: What Comes Next After Brentuximab Vedotin and PD-1 Inhibition?Tamer Othman, Alex Herrera, Matthew Mei
Current Treatment Options in Oncology|April 24, 2024
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?Hua-Jay J Cherng, Alex Herrera
Critical Reviews in Oncology/Hematology|September 7, 2024
Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphomaJeremy S Abramson, Robert Stuver, Alex Herrera, et al.
International Journal of Radiation Oncology, Biology, Physics|February 17, 2022
Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell TransplantColton Ladbury, Swetha Kambhampati Thiruvengadam, Tamer Othman, et al.
Transplantation and Cellular Therapy|June 7, 2022
ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) TherapyNausheen Ahmed, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.
Blood Advances|December 21, 2023
Advanced practice providers in hematology: actionable findings from national paired APP and physician surveysAriela L Marshall, Leah E Masselink, Peter A Kouides, et al.
American Journal of Clinical Pathology|June 29, 2026
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myelomaV Rakesh Sethapati, Vu Ngo, Alexey Danilov, et al.
Transplantation and Cellular Therapy|May 20, 2026
High incidence of cytomegalovirus infection in patients receiving standard of care CD19- or BCMA-targeted CAR T-cell therapies for hematologic malignanciesTamer Othman, John H Baird, Yan Wang, et al.
Cancers|March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell LymphomaColton Ladbury, Savita Dandapani, Claire Hao, et al.
Pageof 3